Canadian Respiratory Journal

Research Article

Readability and Suitability of COPD Consumer Information

Table 3


Inhaler	Type	Manufacturer

Advair Diskus	DPI	GlaxoSmithKline
Airomir	MDI	Valeant Canada LP
Anoro Ellipta	DPI	GlaxoSmithKline
Apo-Salvent CFC Free	MDI	Apotex
Atrovent HFA	MDI	Boehringer Ingelheim
Breo Ellipta	DPI	GlaxoSmithKline
Bricanyl Turbuhaler	DPI	AstraZeneca
Combivent Respimat	SMI	Boehringer Ingelheim
Duaklir Genuair	DPI	AstraZeneca
Foradil Aerolizer	DPI	Novartis Pharmaceuticals
Incruse Ellipta	DPI	GlaxoSmithKline
Inspiolto Respimat	SMI	Boehringer Ingelheim
Novo-Salbutamol HFA	MDI	Teva Canada
Onbrez Breezhaler	DPI	Novartis Pharmaceuticals
Salbutamol HFA	MDI	Sanis Health
Seebri Breezhaler	DPI	Novartis Pharmaceuticals
Serevent Diskhaler Disk	DPI	GlaxoSmithKline
Serevent Diskus	DPI	GlaxoSmithKline
Spiriva	DPI (handihaler)	Boehringer Ingelheim
Spiriva Respimat	SMI	Boehringer Ingelheim
Striverdi Respimat	SMI	Boehringer Ingelheim
Symbicort Turbuhaler	DPI	AstraZeneca
Tudorza Genuair	DPI	AstraZeneca
Ultibro Breezhaler	DPI	Novartis Pharmaceuticals
Ventolin Diskus	DPI	GlaxoSmithKline
Ventolin HFA	HFA	GlaxoSmithKline

Generic products; only 100/25 mcg/dose indicated in COPD; approved by Health Canada but not currently marketed; MDI: metered dose inhaler; DPI: dry powdered inhaler; SMI: soft mist inhaler.